COMBIOXIN S.A.
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe bacterial infections and combat antibiotics resistance.
COMBIOXIN S.A.
Social Links:
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.combioxin.com
Total Employee:
1+
Status:
Active
Contact:
+41 22 810 8372
Total Funding:
101.03 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Mobile Non Scaleable Content IPv6 Google Maps ReCAPTCHA WP Super Cache
Similar Organizations
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - Combioxin S.A.
Foundation for Technological Innovation (FIT)
Foundation for Technological Innovation (FIT) investment in Debt Financing - Combioxin S.A.
Official Site Inspections
http://www.combioxin.com Semrush global rank: 5.2 M Semrush visits lastest month: 1.56 K
- Host name: h2web27.infomaniak.ch
- IP address: 128.65.195.32
- Location: Satigny Switzerland
- Latitude: 46.2146
- Longitude: 6.0355
- Timezone: Europe/Zurich
- Postal: 1242
More informations about "Combioxin S.A."
Combioxin S.A. - Crunchbase Company Profile & Funding
Combioxin S.A. closed its last funding round on May 15, 2019 from a Non-equity Assistance round. Who are Combioxin S.A. 's competitors? Alternatives and possible competitors to …See details»
Combioxin 2025 Company Profile: Valuation, Funding & Investors
Combioxin was founded in 2015. Where is Combioxin headquartered? Combioxin is headquartered in Epalinges, Switzerland. What is the size of Combioxin? Combioxin has 3 …See details»
Combioxin SA - BioAlps
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
Combioxin SA • Biopôle • Switzerland
Combioxin is committed to the development of disruptive treatments for severe infections and has developed CAL02, a novel first-in-class antitoxin agent for the treatment of severe pneumonia. …See details»
Combioxin SA - Swiss Biotech
Combioxin SA . Swiss Biotech Association. Not a member. Profile News, events, jobs ... Type of organization. Private company. Year of foundation. 2015. Number of employees in …See details»
PR_CX_180417 | Combioxin
About Combioxin: Combioxin SA is a Swiss-based clinical-stage biotechnology company founded in 2015. The company is committed to the development of disruptive treatments for severe …See details»
Combioxin SA - VentureRadar
"Swiss biotech Combioxin has developed a new way to treat serious infections, by neutralising toxins made by pathogens. Combioxin’s approach could introduce a new treatment option to …See details»
Combioxin SA Company Profile | Epalinges, VAUD, Switzerland ...
Find company research, competitor information, contact details & financial data for Combioxin SA of Epalinges, VAUD. Get the latest business insights from Dun & Bradstreet.See details»
Combioxin - Products, Competitors, Financials, Employees, …
Combioxin is a biotechnology company focused on developing first-in-class drugs for severe infections in the healthcare sector. Their main offerings include innovative anti-virulence drugs …See details»
Combioxin S.A. - Contacts, Employees, Board Members
Combioxin S.A. is clinical-stage biotech company. Start Free Trial . Chrome ExtensionSee details»
PR_CX_191112 | Combioxin
November 12, 2019, Geneva – Combioxin SA met today with the Innovation Task Force (ITF) of the European Medicines Agency (EMA) ... The World Health Organization estimates that …See details»
Improving the fate of severely infected patients: the promise of …
CONTACT Samareh Azeredo da Silveira [email protected] Combioxin SA, 8 rue de la Rôtisserie, Geneva 1204, Switzerland EXPERT REVIEW OF ANTI-INFECTIVE …See details»
Combioxin SA - VentureRadar
Swiss biotech Combioxin has developed a new way to treat serious infections, by neutralising toxins made by pathogens. Combioxin’s approach could introduce a new treatment option to …See details»
Combioxin SA has moved to the Biopôle • Biopôle • Switzerland
Combioxin SA, a clinical-stage biotechnology company, is happy to announce that it has moved its offices to the Biopôle in Epalinges, Switzerland. Combioxin is committed to the …See details»
Combioxin SA - startup.ch
Combioxin SA: Combioxin is a Swiss-based biotechnology company dedicated to the development of first-in-class life-saving drugs for severe infections. The company is currently …See details»
PIPELINE | Combioxin
Combioxin entered into a worlwide licensing agreement with Eagle Pharmaceuticals for the commercial rights to CAL02. Visit Eagle Pharmaceutical’s website.. Selected publications. …See details»
Combioxin enters into licensing agreement for its treatment …
Aug 27, 2021 Combioxin is a Swiss-based biotechnology company dedicated to the development of first-in-class life-saving drugs for severe infections. The company is currently …See details»
Combioxin S.A. Company Information - Funding, Investors, and More
Website: https://combioxin.com; Company size: 1 - 11 employees Headquarters: Geneva, Switzerland Founded: 2015 Social accounts: Linkedin; Similar startup. Neurosterix Seedtable …See details»
NEWS - Combioxin
May 2, 2019 Combioxin announces worldwide licensing agreement with Eagle Pharmaceuticals for Phase 2b/3, first-in-class anti-virulence agent CAL02 for the treatment of severe …See details»